Literature DB >> 28550447

Trends in Surgical Research in Head and Neck Cancer.

Genrich Tolstonog1, Christian Simon2.   

Abstract

OPINION STATEMENT: The task of surgical research is to improve the efficacy of available surgical therapeutic modalities, develop new ones, and balance this well with favorable functional outcome. Therefore, surgical research is composed of a translational and a clinical component. In translational surgical research, animal models are used to better understand the biology of head and neck cancers, but even more importantly, the biology of changes to the disease and the microenvironment created by surgical interventions. Animal models additionally allow for the development of image-guided surgery systems, novel strategies of intraoperative adjuvant treatment, and patient "avatars" to test innovative anticancer drug combinations. In clinical surgical research, surgical techniques are validated in clinical trials for effectiveness of tumor control and improvement of functional recovery of the patient. In conclusion, surgical research for head and neck cancer is an active field spanning across the entire breadth of basic and clinical science devoted to a better understanding of what surgery does to the disease and to the patient.

Entities:  

Keywords:  Animal models; Clinical trials; HNSCC; Head and neck cancer; Translational research

Mesh:

Year:  2017        PMID: 28550447     DOI: 10.1007/s11864-017-0475-z

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  58 in total

Review 1.  Facial transplantation.

Authors:  Kumaran Shanmugarajah; Shehan Hettiaratchy; Peter E M Butler
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2012-08       Impact factor: 2.064

Review 2.  Clinical outcomes of facial transplantation: a review.

Authors:  Kumaran Shanmugarajah; Shehan Hettiaratchy; Alex Clarke; Peter E M Butler
Journal:  Int J Surg       Date:  2011-10-01       Impact factor: 6.071

3.  Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma.

Authors:  Steven B Chinn; Owen A Darr; John H Owen; Emily Bellile; Jonathan B McHugh; Matthew E Spector; Silvana M Papagerakis; Douglas B Chepeha; Carol R Bradford; Thomas E Carey; Mark E P Prince
Journal:  Head Neck       Date:  2014-03-25       Impact factor: 3.147

4.  A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.

Authors:  Konrad Klinghammer; Jan-Dirk Raguse; Thomas Plath; Andreas E Albers; Korinna Joehrens; Andre Zakarneh; Bernadette Brzezicha; Annika Wulf-Goldenberg; Ulrich Keilholz; Jens Hoffmann; Iduna Fichtner
Journal:  Int J Cancer       Date:  2014-11-26       Impact factor: 7.396

5.  Development of bioengineered human larynx.

Authors:  Silvia Baiguera; Alessandro Gonfiotti; Massimo Jaus; Camilla E Comin; Milena Paglierani; Costantino Del Gaudio; Alessandra Bianco; Domenico Ribatti; Paolo Macchiarini
Journal:  Biomaterials       Date:  2011-04-06       Impact factor: 12.479

6.  Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.

Authors:  S Schmitz; M Hamoir; H Reychler; M Magremanne; B Weynand; R Lhommel; F-X Hanin; T Duprez; N Michoux; D Rommel; M Lonneux; N Cappoen; A Gillain; J-P Machiels
Journal:  Ann Oncol       Date:  2013-05-23       Impact factor: 32.976

7.  Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinoma.

Authors:  Fabienne Thomas; Philippe Rochaix; Adil Benlyazid; Jérôme Sarini; Michel Rives; Jean Louis Lefebvre; Ben C Allal; Frédéric Courbon; Etienne Chatelut; Jean-Pierre Delord
Journal:  Clin Cancer Res       Date:  2007-12-01       Impact factor: 12.531

8.  Surgical trials in head and neck oncology: Renaissance and revolution?

Authors:  Richard J Shaw; F Christopher Holsinger; Vinidh Paleri; Mererid Evans; Catrin Tudur-Smith; Robert L Ferris
Journal:  Head Neck       Date:  2015-04-06       Impact factor: 3.147

9.  Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.

Authors:  Anthony C Nichols; John Yoo; J Alex Hammond; Kevin Fung; Eric Winquist; Nancy Read; Varagur Venkatesan; S Danielle MacNeil; D Scott Ernst; Sara Kuruvilla; Jeff Chen; Martin Corsten; Michael Odell; Libni Eapen; Julie Theurer; Philip C Doyle; Bret Wehrli; Keith Kwan; David A Palma
Journal:  BMC Cancer       Date:  2013-03-20       Impact factor: 4.430

10.  Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.

Authors:  Shaohua Peng; Chad J Creighton; Yiqun Zhang; Banibrata Sen; Tuhina Mazumdar; Jeffery N Myers; Stephen Y Lai; Adrian Woolfson; Matthew V Lorenzi; Diana Bell; Michelle D Williams; Faye M Johnson
Journal:  J Transl Med       Date:  2013-08-27       Impact factor: 5.531

View more
  3 in total

1.  Postoperative Complications of Free Flap Reconstruction in Moderate-Advanced Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study Based on Real-World Data.

Authors:  Delong Li; Chong Wang; Wei Wei; Bo Li; Huan Liu; Aoming Cheng; Qifang Niu; Zhengxue Han; Zhien Feng
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

2.  Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.

Authors:  Yifei Chen; Jin Nie; Xiangsheng Li; Tao Fan; Xiaowen Deng; Dan Liang; Guilin Song
Journal:  J Immunol Res       Date:  2021-01-08       Impact factor: 4.818

3.  A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma.

Authors:  Huili Wu; Xiao Zhao; Tingting Zhu; Di Rong; Ying Wang; Diya Leng; Daming Wu
Journal:  Front Genet       Date:  2022-07-11       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.